MCL coexpression mm9:1955
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:118280270..118280329,- | p1@Cant1 |
Mm9::chr17:56416141..56416172,- | p2@Ticam1 |
Mm9::chr17:56416173..56416196,- | p1@Ticam1 |
Mm9::chr1:94807382..94807411,+ | p1@Rnpepl1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0002281 | macrophage activation during immune response | 0.00478981928606648 |
GO:0002275 | myeloid cell activation during immune response | 0.00478981928606648 |
GO:0004382 | guanosine-diphosphatase activity | 0.00478981928606648 |
GO:0045134 | uridine-diphosphatase activity | 0.00478981928606648 |
GO:0032481 | positive regulation of interferon type I production | 0.00478981928606648 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 0.00478981928606648 |
GO:0032479 | regulation of interferon type I production | 0.00478981928606648 |
GO:0045359 | positive regulation of interferon-beta biosynthetic process | 0.00558781633547003 |
GO:0032608 | interferon-beta production | 0.00558781633547003 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 0.00558781633547003 |
GO:0043496 | regulation of protein homodimerization activity | 0.00558781633547003 |
GO:0045350 | interferon-beta biosynthetic process | 0.00558781633547003 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 0.00797909631221298 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 0.00797909631221298 |
GO:0002224 | toll-like receptor signaling pathway | 0.00797909631221298 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 0.00797909631221298 |
GO:0002221 | pattern recognition receptor signaling pathway | 0.00797909631221298 |
GO:0043393 | regulation of protein binding | 0.00797909631221298 |
GO:0032755 | positive regulation of interleukin-6 production | 0.00797909631221298 |
GO:0009134 | nucleoside diphosphate catabolic process | 0.00797909631221298 |
GO:0045073 | regulation of chemokine biosynthetic process | 0.00797909631221298 |
GO:0009261 | ribonucleotide catabolic process | 0.00797909631221298 |
GO:0032606 | interferon type I production | 0.00797909631221298 |
GO:0050755 | chemokine metabolic process | 0.00797909631221298 |
GO:0045351 | interferon type I biosynthetic process | 0.00797909631221298 |
GO:0042033 | chemokine biosynthetic process | 0.00797909631221298 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 0.00797909631221298 |
GO:0032602 | chemokine production | 0.00797909631221298 |
GO:0032675 | regulation of interleukin-6 production | 0.00797909631221298 |
GO:0032760 | positive regulation of tumor necrosis factor production | 0.00797909631221298 |
GO:0002218 | activation of innate immune response | 0.00797909631221298 |
GO:0002758 | innate immune response-activating signal transduction | 0.00797909631221298 |
GO:0042116 | macrophage activation | 0.00797909631221298 |
GO:0002366 | leukocyte activation during immune response | 0.00797909631221298 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 0.00797909631221298 |
GO:0051607 | defense response to virus | 0.00797909631221298 |
GO:0002263 | cell activation during immune response | 0.00797909631221298 |
GO:0017110 | nucleoside-diphosphatase activity | 0.00797909631221298 |
GO:0032680 | regulation of tumor necrosis factor production | 0.00797909631221298 |
GO:0045088 | regulation of innate immune response | 0.00797909631221298 |
GO:0043330 | response to exogenous dsRNA | 0.00797909631221298 |
GO:0045089 | positive regulation of innate immune response | 0.00797909631221298 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 0.00857241975304969 |
GO:0032496 | response to lipopolysaccharide | 0.00893560848184599 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 0.00893560848184599 |
GO:0043331 | response to dsRNA | 0.00907473004625096 |
GO:0030890 | positive regulation of B cell proliferation | 0.00907473004625096 |
GO:0009132 | nucleoside diphosphate metabolic process | 0.00907473004625096 |
GO:0051092 | activation of NF-kappaB transcription factor | 0.0093813606238673 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 0.0093813606238673 |
GO:0032640 | tumor necrosis factor production | 0.00985383036871236 |
GO:0032635 | interleukin-6 production | 0.0103080576010432 |
GO:0046209 | nitric oxide metabolic process | 0.0103543449226258 |
GO:0002237 | response to molecule of bacterial origin | 0.0103543449226258 |
GO:0006809 | nitric oxide biosynthetic process | 0.0103543449226258 |
GO:0008624 | induction of apoptosis by extracellular signals | 0.011353845313042 |
GO:0051098 | regulation of binding | 0.011353845313042 |
GO:0001819 | positive regulation of cytokine production | 0.011353845313042 |
GO:0051091 | positive regulation of transcription factor activity | 0.011353845313042 |
GO:0030888 | regulation of B cell proliferation | 0.0117222027855616 |
GO:0009166 | nucleotide catabolic process | 0.0120784228007324 |
GO:0051090 | regulation of transcription factor activity | 0.0135018813592137 |
GO:0050871 | positive regulation of B cell activation | 0.0138183109552751 |
GO:0002274 | myeloid leukocyte activation | 0.0139074902637953 |
GO:0042100 | B cell proliferation | 0.0139074902637953 |
GO:0001817 | regulation of cytokine production | 0.0152161316117047 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.015986540668856 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 0.0169605190275 |
GO:0002757 | immune response-activating signal transduction | 0.0169605190275 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 0.0169605190275 |
GO:0050671 | positive regulation of lymphocyte proliferation | 0.0169605190275 |
GO:0004177 | aminopeptidase activity | 0.0169605190275 |
GO:0050864 | regulation of B cell activation | 0.0169605190275 |
GO:0002764 | immune response-regulating signal transduction | 0.0171825786600536 |
GO:0045727 | positive regulation of translation | 0.0178438091349992 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.018926585343238 |
GO:0009615 | response to virus | 0.0212804042114314 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.021435129115765 |
GO:0050670 | regulation of lymphocyte proliferation | 0.0218761102146985 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.0218761102146985 |
GO:0009891 | positive regulation of biosynthetic process | 0.0218761102146985 |
GO:0042089 | cytokine biosynthetic process | 0.0242682940231048 |
GO:0051251 | positive regulation of lymphocyte activation | 0.0242682940231048 |
GO:0042107 | cytokine metabolic process | 0.0242682940231048 |
GO:0009967 | positive regulation of signal transduction | 0.0255498198958522 |
GO:0009259 | ribonucleotide metabolic process | 0.0271877884826472 |
GO:0051247 | positive regulation of protein metabolic process | 0.0272577224380037 |
GO:0032943 | mononuclear cell proliferation | 0.0277664721503258 |
GO:0046651 | lymphocyte proliferation | 0.0277664721503258 |
GO:0044271 | nitrogen compound biosynthetic process | 0.0281969685644931 |
GO:0002253 | activation of immune response | 0.0282524973307041 |
GO:0051249 | regulation of lymphocyte activation | 0.0301130537999143 |
GO:0042113 | B cell activation | 0.0305037231379708 |
GO:0050865 | regulation of cell activation | 0.0305325895451643 |
GO:0045087 | innate immune response | 0.0312599260324409 |
GO:0008238 | exopeptidase activity | 0.0326632198979232 |
GO:0050778 | positive regulation of immune response | 0.0330106595549708 |
GO:0002684 | positive regulation of immune system process | 0.0333490289481452 |
GO:0001816 | cytokine production | 0.0333490289481452 |
GO:0050776 | regulation of immune response | 0.0369171102606543 |
GO:0009617 | response to bacterium | 0.0369171102606543 |
GO:0002682 | regulation of immune system process | 0.0369171102606543 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0378444925897996 |
GO:0006917 | induction of apoptosis | 0.0409042361758859 |
GO:0012502 | induction of programmed cell death | 0.0409042361758859 |
GO:0006417 | regulation of translation | 0.0411420194124377 |
GO:0002252 | immune effector process | 0.0419927925617817 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0428272703558116 |
GO:0009889 | regulation of biosynthetic process | 0.047277316629461 |
GO:0043065 | positive regulation of apoptosis | 0.0489525028519074 |
GO:0051707 | response to other organism | 0.0489525028519074 |
GO:0043068 | positive regulation of programmed cell death | 0.0489525028519074 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |